A regulatory loop among CD276, miR-29c-3p, and Myc exists in cancer cells against natural killer cell cytotoxicity

Chin-Cheng Lee1, Kuo-Hao Ho2, Tzu-Wen Huang3

  • 1Department of Pathology and Laboratory Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.

Life Sciences
|April 2, 2021
PubMed
Abstract

Insights

A novel regulatory loop involving cluster of differentiation 276 (CD276), Myc, and microRNA (miR)-29c-3p was identified. This pathway impacts cancer cell evasion of natural killer (NK) cell immunity, offering potential targets for cancer immunotherapy.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Immune checkpoints are crucial for regulating immune responses and preventing autoimmunity.
  • While cancer immunotherapies have improved outcomes, not all patients respond effectively.
  • Identifying novel immune checkpoints is vital for advancing cancer treatment.

Purpose of the Study:

  • To explore the role of cluster of differentiation 276 (CD276), also known as B7H3, as a potential immune checkpoint in cancer.
  • To elucidate the molecular mechanisms underlying CD276's function in the tumor microenvironment.
  • To investigate the interplay between CD276, microRNAs, and oncogenic pathways in cancer progression.

Main Methods:

  • Pan-cancer data analysis using The Cancer Genome Atlas (TCGA).
  • Investigation of correlations between CD276 expression, natural killer (NK) cell infiltration, and microRNA levels.
  • Gene set enrichment analyses to identify CD276-associated molecular pathways.

Main Results:

  • CD276 was identified as a risk gene in multiple cancers and negatively correlated with NK cell cytotoxicity.
  • A negative regulatory loop was found between CD276, Myc, and microRNA (miR)-29c-3p.
  • CD276 overexpression suppressed miR-29c-3p, enhancing Myc activity and promoting cancer cell immune evasion.
  • miR-29c-3p overexpression rescued CD276-impaired NK cell function.

Conclusions:

  • A novel CD276-Myc-miR-29c-3p regulatory axis influences cancer cell resistance to NK cell-mediated killing.
  • This pathway represents a potential therapeutic target for overcoming immune evasion in cancer immunotherapy.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.5K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
5.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.3K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
7.6K